Abstract:Aim: To observe the effect of long-time intake of phecyclidine (PCP), the receptor antagonist of noncompetitive N-methyl-D-aspartic acid (NMDA), on the social behavior of mice, and establish animal models of schizophrenia as well as observe the interventional effects of different antipsychotics on mouse models. Methods: The experiment was conducted in the Animal Laboratory of Medical Department, Nagoya University of Japan between June and September 2003. 1 First experiment, the effects of PCP on social behavior of mice at different dose and administration time: 60 DDY male mice of 6 months old were randomly divided into 5 groups after 2-week feeding with 12 mice in each group and fed in two separate coops. Mice in high-dose long-term PCP group were treated with 10 mg/kg for 14 days. Mice in low-dose long-term PCP group were treated with 3 mg/kg for 14 days, and mice in long-term administration control group were treated with normal saline for 14 days. Mice in high-dose short-term PCP group were treated with 3 mg/kg for 14 days. Mice in long-term administration control group were treated with normal saline for 14 days. Mice in high-dose short-term PCP group were treated with 10 mg/kg for 7 days. Mice in short-term administration control group were treated with normal saline for 7 days. All mice were administrated by subcutaneous injection. The social behaviors of mice were tested respectively on the 36rd, 7th, 14th, 21st and 28th day after drug withdrawal. 2 Second experiment. The effects of antipsychotics PCP on the social behaviors of mice: another 60 mice were randomly divided into 5 groups with 12 rats in each group, which were fed in two separate coops. Mice in high-dose clozapine group were continuously injected with high-dose PCP for 14 days, and then were injected with clozapine 3 mg/kg per day for 7 days at 14 days after withdrawal. Mice in high-dose aloperidin group were continuously injected with high dose of PCP for 14 days and then were injected with aloperidin 3 mg/kg per day for 7 days at 14 days after withdrawal. Mice in low-dose aloperidin group were continuously injected with high-dose alperidin for 14 days, and then were injected with alperidin 1 mg/kg per day for 7 days. Mice in the normal saline group were continuously injected with normal saline for 14 days and then were injected with normal saline for 7 days at 14 days after withdrawal. Social behaviors were tested on withdrawal day and 7 days after withdrawal. Results: All of 120 mice were involved in the analysis of results, and no one withdrew from the study. 1 The first experiment showed that the social behavior of rats in the high-dose long-term PCP group were reduced respective on the 3rd, 7th, 14th, 21st and 28th day after withdrawal [(16.8±4.3), (13.4±3.5), (15.5±3.9), (28.2±5.0), (32.5±4.9) s,P < 0.01], which continued on the 28th day after withdrawal. 2 The second experiment showed that the social behavior deficit of mice induced by continuous administration of high-dose PCP was obviously ameliorated at 7 days after continuous treatment with clozapine [before administration: (13.8±1.6) s, the day of drug withdrawal: (143.1±36.1) s, 7 days after withdrawal: (64.8±10.3) s, P < 0.01,P < 0.05]. There was no changes in the social behavior deficit of mice induced by low-dose of clozapine and PCP at 7 days after that. The effect of clozapine on social behavior of mice induced by PCP was attenuated at one week after withdrawal. There was no ameliorating effect of aloperidin on the social behavior of mice induced by PCP. Conclusion: The social behavior of mice can be reduced by long-term administration of PCP (10 mg/kg), while the clozapine (10 mg/kg·day) has anti-effect on that mentioned above, which indicate that long-term administration of PCP, which can change the social behavior of mice, can be taken as the antipsychotics in the treatment of social behavior animal model of schizophrenia.

The Effects of Donepezil on Phencyclidine-Induced Cognitive Deficits in a Mouse Model of Schizophrenia

ChemInform Abstract: Donepezil‐Induced Neuroprotection of Acetylcholinergic Neurons in Olfactory Bulbectomized Mice

Adjunctive Treatment for Cognitive Impairment in Patients with Chronic Schizophrenia: a Double-Blind, Placebo-Controlled Study.

Fingolimod Ameliorates Schizophrenia‐like Cognitive Impairments Induced by Phencyclidine in Male Rats

Fingolimod ameliorates cognitive impairments in a phencyclidine-induced rat model of schizophrenia

Hippocampal Proteomic Alteration in Triple Transgenic Mouse Model of Alzheimer's Disease and Implication of PINK 1 Regulation in Donepezil Treatment

Donepezil-induced neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice]

Effects of Donepezil Treatment on Plasma and Urine Metabolites in Amyloid Beta-Induced Alzheimer's Disease Rats

Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping

Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus

Social behavior in animal model of schizophrenia and the effects of antipsychotics

Effects of donepezil on cognitive functions and the expression level of β-amyloid in peripheral blood of patients with Alzheimer's disease

Low-dose diazepam improves cognitive function in APP/PS1 mouse models: Involvement of AMPA receptors

Propantheline Attenuates the Peripheral Side Effects of Donepezil Without Affecting Its Antiamnestic Properties in Cerebral Ischemic Mice

Synergistic Effect of Combined Treatment with Risperidone and Galantamine on Phencyclidine-Induced Impairment of Latent Visuospatial Learning and Memory: Role of Nachr Activation-Dependent Increase of Dopamine D1 Receptor-Mediated Neurotransmission

Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action

Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of Β-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer’s Disease

Protective Effects of Shi-Zhen-An-Shen Decoction on the Cognitive Impairment in MK801-Induced Schizophrenia Model

Enhanced anti-amnestic effect of donepezil by <i>Ginkgo biloba</i> extract (EGb 761) <i>via</i> further improvement in pro-cholinergic and antioxidative activities

Studies of the Anti-amnesic Effects and Mechanisms of Single and Combined Use of Donepezil and Ginkgo Ketoester Tablet on Scopolamine-Induced Memory Impairment in Mice

P2-105: the Effects of Donepezil on Alzheimer's Disease: A Diffusion Tensor Imaging Study at 3T